GHRS GH Research PLC
Healthcare$23.15+4.66%ClosedMarket Cap: $1.59B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
5.21
P/S
0.00
EV/EBITDA
-21.83
DCF Value
$4.04
FCF Yield
-3.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-19.8%
ROA
-20.5%
ROIC
-25.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-18.7M | $-19.0M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-16.7M | $-14.1M | $— | — |
| FY null | $0.00 | -Infinity% | $-60.7M | $-48.3M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-16.5M | $-14.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-14.7M | $-9.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-12.7M | $-10.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-12.9M | $-8.8M | $— | — |
| FY null | $0.00 | NaN% | $-50.3M | $-39.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-12.6M | $-12.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-13.2M | $-10.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-11.5M | $-7.7M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-11.2M | $-11.3M | $-0.22 | — |